https://pubmed.ncbi.nlm.nih.gov/40349140/
Evaluation of the effectiveness and safety of avapritinib in real-world Spanish cases with...
Avapritinib extends PFS and OS among patients with PDGFRA D842V-mutant GIST in real-world practice, mirroring pivotal trial outcomes. Its substantial activity...
https://www.cancer.gov/news-events/cancer-currents-blog/2020/avapritinib-gist-pdgfra-alteration-fda-approval
Avapritinib Approved for GIST with PDGFRA Gene Alteration - NCI
Avapritinib (Ayvakit) has been approved for adults with gastrointestinal stromal tumor (GIST) whose tumors have an alteration in a portion of the PDGFRA gene...
approvedgistpdgfragenealteration